[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
October 26, 1994

More Conflicts of Interest: Review Articles Sponsored by the Pharmaceutical Industry-Reply

Author Affiliations

Technology Resource Group Sacramento, Calif
American Society of Law Boston, Mass

JAMA. 1994;272(16):1254. doi:10.1001/jama.1994.03520160037032

In Reply.  —In the context raised by Dr Nahata, industry support for the publication of a review article should be viewed as part of a company's marketing efforts, namely, to provide an incentive for a professional to publish his or her opinion about the company's product. Presumably, the company's fiscal motives are to encourage others to rely on the author's assessment of the product and, thus, influence sales. Companies may benefit most from supporting well-written articles by skeptical academics who happen to agree with company positions. Nahata differs from our view insofar as he suggests that the content of such articles are controlled by the sponsoring company. Product endorsement articles lacking objectivity seldom survive journal peer review processes. Further, most scholars realize that it reflects poorly on their academic career if objectivity and professionalism are influenced by financial inducements.Many peer-reviewed publications, including JAMA, require authors to disclose sources of

First Page Preview View Large
First page PDF preview
First page PDF preview